TABLE 4.
Target | Gene | IC90 for planktonic cells (μg/ml) | BMIC (μg/ml) |
|||
---|---|---|---|---|---|---|
Biofilm formation |
Preformed biofilm |
|||||
BMIC50 | BMIC90 | BMIC50 | BMIC90 | |||
Drug response | TAC1 | 1 | 2 | 4 | 8–16 | 32 |
RME1 | 2 | 1–2 | 4 | 8 | 32 | |
CRZ1 | 2 | 1–2 | 2 | 2 | 8 | |
MRR1 | 1–2 | 2 | 4 | 2–4 | 8 | |
NDT80 | 1 | 1–2 | 2 | 32–64 | 64 | |
FCR1 | 1–2 | 2 | 4 | 8–16 | 32 | |
CAP1 | 1 | 2 | 4 | 8 | 16 | |
Stress response | WAR1 | 1 | 0.5 | 2 | 8 | 32 |
MNL1 | 2 | 2 | 2 | 8–16 | 32 | |
NRG1 | 1–2 | NDb | ND | ND | 16 | |
Cell wall | RLM1 | 2 | 1–2 | 2 | 2–4 | 8 |
CAS5 | 2 | 2 | 4 | 2–4 | 8 | |
SKO1 | 1 | 1–2 | 2–4 | 8 | 32 | |
Cell respiration/metabolism | HAP5 | 1 | 1–2 | 2 | 32–64 | 64 |
HAP3 | 1 | 1 | 4 | 8–16 | 32 | |
Ergosterol | UPC2 | 2 | 2–4 | 4–8 | 2–4 | 8 |
Adherence, biofilm, and virulence | EFG1 | 0.5–1 | 1–2 | 2 | 4–8 | 8–16 |
ACE2a | 1 | 4 | 8–16 | 2–4 | 4–8 | |
BCR1a | 2 | 2–8 | 8 | 16–32 | 32 | |
C. albicans SN152 | Parental strain | 1–2 | 2 | 4 | 8 | 16–32 |
Not a good biofilm-forming strain.
ND, not defined.